Results 181 to 190 of about 27,152 (204)
Some of the next articles are maybe not open access.

Polymyositis: does it really exist as a distinct clinical subset?

Current Opinion in Rheumatology, 2021
Purpose of review To summarize information on polymyositis; diagnosis, definitions, published data and opinions. Recent findings Polymyositis originally referred to inflammatory muscle diseases presenting with muscle weakness and inflammatory cell ...
V. Leclair   +3 more
semanticscholar   +1 more source

Risk Prediction Modeling Based on a Combination of Initial Serum Biomarker Levels in Polymyositis/Dermatomyositis–Associated Interstitial Lung Disease

Arthritis & Rheumatology, 2020
To establish predictive models for mortality in patients with polymyositis/dermatomyositis–associated interstitial lung disease (PM/DM‐ILD) using a combination of initial serum biomarker levels.
T. Gono   +17 more
semanticscholar   +1 more source

Elevated serum YKL-40 correlates with clinical characteristics in patients with polymyositis or dermatomyositis

Annals of Clinical Biochemistry, 2018
Background Serum YKL-40 has been proved to be a promising biomarker for estimating the disease activity of several autoimmune diseases. However, its utility in polymyositis or dermatomyositis has not been established.
Ming-Zhu Gao   +5 more
semanticscholar   +1 more source

Mortality of Chinese patients with polymyositis and dermatomyositis

Clinical Rheumatology, 2020
Xinlei Yang   +6 more
semanticscholar   +1 more source

Risk of Malignancy in Dermatomyositis and Polymyositis

Journal of Cutaneous Medicine and Surgery, 2017
J. Qiang,   +3 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy